For Immediate Release: June 17, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA’s National Center for Toxicological Research (NCTR) announced the publication of …
For Immediate Release: June 17, 2022 Today, the U.S. Food and Drug Administration authorized emergency use of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include use in children down to 6 months …
For Immediate Release: June 15, 2022 Today, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency’s recent increased flexibilities. Company …
For Immediate Release: June 14, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA’s Center for Devices and Radiological Health (CDRH) announced plans to study how …
For Immediate Release: June 13, 2022 Today, the U.S. Food and Drug Administration approved Olumiant (baricitinib) oral tablets to treat adult patients with severe alopecia areata, a disorder that often appears as patchy baldness and affects more than 300, …
For Immediate Release: December 06, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued a final guidance, Homeopathic Drug Products, describing the agency’s approach …
For Immediate Release: December 06, 2022 Statement From: Robert M. Califf, M.D., MACC Commissioner of Food and Drugs - Food and Drug Administration In July, I commissioned an external evaluation of the U.S. Food and Drug Administration’s Human Foods …
For Immediate Release: June 10, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA authorized the marketing of two new tobacco products through the Premarket Tobacco Product …
For Immediate Release: June 10, 2022 Today, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency’s recent increased flexibilities. Company …
For Immediate Release: October 06, 2022 Today, the U.S. Food and Drug Administration, in coordination with the Centers for Disease Control and Prevention (CDC), released federal data from the 2022 National Youth Tobacco Survey (NYTS) on e-cigarette use …
For Immediate Release: June 09, 2022 Today, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency’s recent increased flexibilities. Company …
FDA News Release Agency remains committed to updating public about Philips recalled devices For Immediate Release: September 06, 2022 Today, the U.S. Food and Drug Administration is alerting patients, caregivers and health care providers that Philips …
For Immediate Release: September 06, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published the 2022: Advancing Regulatory Science at FDA: Focus Areas of Regulatory …
FDA News Release Next Legends Campaign Aims to Educate Native American Youth About Harms of Vaping through Culturally Specific Ads For Immediate Release: June 08, 2022 Today, the U.S. Food and Drug Administration announced the launch of the “Next Legends” …
For Immediate Release: June 07, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced it is considering a master file pilot program for premarket approval (PMA) …
For Immediate Release: July 06, 2022 Statement From: Robert M. Califf, M.D., MACC Commissioner of Food and Drugs - Food and Drug Administration Susan T. Mayne, Ph.D. Director - Center for Food Safety and Applied Nutrition (CFSAN) The need to diversify and …
FDA News Release New Prescribing Authority Could Improve Access for Some Patients at High Risk for Severe COVID-19 For Immediate Release: July 06, 2022 Today, the U.S. Food and Drug Administration revised the Emergency Use Authorization (EUA) for Paxlovid …
For Immediate Release: July 06, 2022 Today, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency’s recent increased flexibilities. Company …
For Immediate Release: May 31, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: The FDA’s Center for Drug Evaluation and Research (CDER), Center for Devices and Radiological Health (CDRH …
For Immediate Release: May 27, 2022 Today, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula on U.S. store shelves in the coming weeks and months. “We continue to work around …
04 days 03:28:36
